Cargando…
Th1 Cytokine-Secreting Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and Prospective Use in Immunotherapy of Bladder Cancer
Intravesical instillation of Mycobacterium bovis bacillus Calmette-Guérin (BCG) has been used for treating bladder cancer for 3 decades. However, BCG therapy is ineffective in approximately 30–40% of cases. Since evidence supports the T helper type 1 (Th1) response to be essential in BCG-induced tum...
Autores principales: | Luo, Yi, Henning, Jonathan, O'Donnell, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173967/ https://www.ncbi.nlm.nih.gov/pubmed/21941579 http://dx.doi.org/10.1155/2011/728930 |
Ejemplares similares
-
Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy
por: Obaid, Sami, et al.
Publicado: (2011) -
Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer
por: Palmer, Mitchell V., et al.
Publicado: (2018) -
The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
por: Li, Junli, et al.
Publicado: (2021) -
Mycobacterium bovis Bacillus Calmette-Guérin-Induced Macrophage Cytotoxicity against Bladder Cancer Cells
por: Luo, Yi, et al.
Publicado: (2010) -
Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin
por: Samannodi, Mohammed, et al.
Publicado: (2018)